$ATEC

Why is Alphatec Holdings stock surging today?

Alphatec Holdings (ATEC) stock rose 19.1% after CEO Patrick Miles bought 115,000 shares for $1.01M at $8.81 each. The company reported Q2 revenue of $213.5M, up 15% YoY, and reaffirmed FY2026 guidance of $882M. The move coincided with a broader market rebound, with the S&P 500 and Nasdaq gaining 1.0% and 1.1% respectively.

Original reporting
Published Sep 11, 2026, 6:44 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 11, 2026, 6:54 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$ATEC
Bullish
medium confidence
Mentioned
$ATEC
Relevance
6/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$ATECBullishMed
01

Why it matters

The insider purchase adds a fresh catalyst, amplifying the stock's momentum after a weak prior run.

02

Market read

The news provides a new, material catalyst for ATEC, likely influencing short‑term trading decisions.

03

What to watch

Potential dilution from upcoming financing rounds not discussed.

Relevance 6/10Novelty 6/10Timing: afternoon trading today

Background

Alphatec reported Q2 revenue up 15% YoY and reaffirmed FY2026 guidance of $882M.

Company-level read

Ticker impact

$ATECBullishMedium confidence
Context

CEO Patrick Miles bought 115,000 shares for $1.01M, triggering a 19.1% price surge.

Expected impact

Potential continued rally toward $12‑$13 as short interest eases.

Evidence & confidence

The buy is sizable relative to float and follows a low price, likely attracting momentum traders.

Market effects

Spine‑technology sector may see heightened interest in other low‑float peers.

U.S. small‑cap market could benefit from the short‑squeeze narrative.

Limited to U.S. equity markets; no broader macro effect.

Counterpoint

The buy could be a personal hedge; price may be overbought after the sharp rally.

Key entities

  • Patrick Miles

    CEO of Alphatec Holdings who made the insider purchase.

  • Alphatec Holdings

    Spine technology firm listed on NASDAQ.

Related articles

$ATECHighAI 9/10

Alphatec (ATEC) Moves 19.7% Higher: Will This Strength Last?

Alphatec (ATEC) shares rose 19.7% to $10.58 on strong Q2 2026 results, with EPS of $0.07 and revenue of $213.5M. The company expects full-year revenue of $882M. Analysts forecast Q3 EPS of $0.11 and revenue of $224.28M. ClearPoint Neuro (CLPT) also mentioned, up 1.8% to $13.72.

$ATECMedAI 8/10

Alphatec (ATEC) Q2 2026 Earnings Call Transcript

Alphatec Holdings (NASDAQ:ATEC) reported Q2 2026 revenue of $214 million, up 15% year over year, with surgical revenue at $196 million, up 17%. Adjusted EBITDA rose to $36 million, up 53%, with GAAP gross margin 72.2%. Management reaffirmed full-year revenue guidance near $882 million and raised adjusted EBITDA guidance to about $140 million.

$ATECMed

Alphatec (ATEC) Q2 2026 Earnings Call Transcript

Alphatec Holdings (ATEC) reported Q2 2026 revenue of $214 million, up 15% year over year, with surgical revenue at $196 million, up 17%. Adjusted EBITDA rose 53% to $36 million, and GAAP gross margin was 72.2%. Management reaffirmed full-year revenue guidance near $882 million and raised adjusted EBITDA guidance to about $140 million.

$ATECMed

Alphatec Holdings, Inc. Q2 2026 Earnings Call Summary

Alphatec Holdings (ATEC) reported Q2 2026 results driven by 24% growth in new surgeon adoption and 20% procedural volume growth, lifting revenue 15%. Management kept full-year surgical revenue guidance at $805M and raised adjusted EBITDA guidance to $140M. It expects Q3 free cash flow of $4M to $6M and cites margin gains from inventory and supply chain efficiency.